Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 163.07%1.99M | 608.74%1.77M | 133.43%1.27M | -895.99%-453.23K | -163.08%-596.52K | -296.67%-3.16M | -108.43%-347.18K | -193.81%-3.81M | 104.85%56.94K | 117.50%945.72K |
| Net income from continuing operations | -164.24%-11.32M | -173.58%-6.62M | -53.38%-1.97M | -1,351.56%-984.85K | -165.19%-1.74M | 17.14%-4.29M | 16.28%-2.42M | -1,923.41%-1.29M | 110.10%78.69K | 58.17%-657.16K |
| Operating gains losses | -669.99%-658.07K | -442.17%-364.28K | ---240.64K | --0 | ---53.15K | ---85.47K | ---67.19K | ---- | ---- | ---- |
| Depreciation and amortization | 15.26%4.04M | -11.03%1.01M | 40.36%1.06M | 15.88%1.03M | 29.40%938.44K | 14.05%3.51M | -37.72%1.14M | 51.93%758.01K | 86.43%889.32K | 161.92%725.2K |
| Asset impairment expenditure | --4.27M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 26.31%206.74K | 108.44%113.21K | -39.78%37.65K | 72.88%37.65K | -27.25%18.24K | -53.41%163.68K | -68.14%54.32K | -58.88%62.52K | 97.43%21.78K | 40.92%25.07K |
| Other non cashItems | 13.96%3.79M | 193.50%1.82M | -37.80%782.06K | -51.75%406.42K | 28.79%775.44K | 88.28%3.32M | -2.88%621.08K | 436.80%1.26M | 40.59%842.31K | 106.21%602.1K |
| Change In working capital | 128.82%1.67M | 364.98%1.54M | 134.97%1.6M | 46.88%-942.99K | -312.67%-532.77K | -508.68%-5.78M | -92.14%330.78K | -247.55%-4.59M | -19.69%-1.78M | 105.67%250.51K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -193.36%-2.79M | 355.31%1.02M | 94.14%-57.22K |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -532.18%-169.17K | -692.38%-126.43K | ---121.05K |
| -Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 84.14%-57.25K | 72.56%-66.2K | -357.85%-77.93K |
| -Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -133.87%-1.48M | -223.51%-2.68M | 114.59%506.71K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 163.07%1.99M | 608.74%1.77M | 133.43%1.27M | -895.99%-453.23K | -163.08%-596.52K | -296.67%-3.16M | -108.43%-347.18K | -193.81%-3.81M | 104.85%56.94K | 117.50%945.72K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -54.88%-8.67M | -407.89%-2.73M | 30.70%-1.92M | -263.41%-1.55M | -32.27%-2.47M | 63.06%-5.6M | 92.45%-537.67K | 53.72%-2.77M | 79.75%-427.49K | -3,465.92%-1.86M |
| Capital expenditure reported | -48.08%-8.68M | -202.31%-2.51M | 27.03%-2M | ---- | ---- | 61.41%-5.86M | 88.75%-830.51K | 52.38%-2.74M | ---- | ---- |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | -33.35%-2.52M | ---- | ---- | ---- | ---- | -1,553.05%-1.89M |
| Net business purchase and sale | 140.00%10K | --0 | ---- | ---- | ---- | 88.64%-25K | --0 | ---- | ---- | ---- |
| Net other investing changes | -98.03%5.76K | ---220.08K | --73.2K | --93.98K | 103.42%58.67K | 10.24%292.84K | ---- | ---- | ---- | 138.50%28.84K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -54.88%-8.67M | -407.89%-2.73M | 30.70%-1.92M | -263.41%-1.55M | -32.27%-2.47M | 63.06%-5.6M | 92.45%-537.67K | 53.72%-2.77M | 79.75%-427.49K | -3,465.92%-1.86M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -28.54%6.43M | 139.82%831.57K | -100.54%-53.48K | 709.00%2.81M | 244.15%2.84M | -28.66%9M | -171.51%-2.09M | 663.80%9.91M | -74.17%347.08K | -88.28%826.36K |
| Net issuance payments of debt | -16.01%9.04M | 218.39%1.89M | -94.13%636.37K | 457.21%3.28M | 247.28%3.23M | 99.79%10.76M | -144.88%-1.6M | 10,524.74%10.84M | -76.05%588.25K | 277.45%930.55K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---1M | -0.59%1M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | -99.69%20.52K | 105.33%13.79K | --0 | --0 | -99.85%6.72K |
| Interest paid (cash flow from financing activities) | -46.32%-2.61M | -109.35%-1.06M | 25.28%-689.85K | -94.84%-469.88K | -249.54%-387.68K | -222.92%-1.78M | -15.27%-505.65K | -824.38%-923.24K | ---241.17K | -755.06%-110.91K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -28.54%6.43M | 139.82%831.57K | -100.54%-53.48K | 709.00%2.81M | 244.15%2.84M | -28.66%9M | -171.51%-2.09M | 663.80%9.91M | -74.17%347.08K | -88.28%826.36K |
| Net cash flow | ||||||||||
| Beginning cash position | 206.12%364.08K | -92.51%250K | 30,093.52%946.57K | 446.74%145.43K | 206.12%364.08K | -88.68%118.93K | 1,611.94%3.34M | -99.61%3.14K | -99.03%26.6K | -88.68%118.93K |
| Current changes in cash | -200.80%-247.11K | 95.53%-133.03K | -120.89%-696.57K | 3,514.17%801.14K | -136.81%-218.65K | 126.30%245.15K | -3,811.69%-2.97M | 640.49%3.33M | 98.79%-23.47K | -105.42%-92.33K |
| End cash Position | -67.87%116.97K | -67.87%116.97K | -92.51%250K | 30,093.52%946.57K | 446.74%145.43K | 206.12%364.08K | 206.12%364.08K | 1,611.94%3.34M | -99.61%3.14K | -99.03%26.6K |
| Free cash from | 25.81%-6.69M | 36.78%-744.51K | 88.92%-726.29K | -514.78%-2.1M | -229.41%-3.12M | 33.63%-9.02M | 63.90%-1.18M | -286.73%-6.55M | 89.42%-341.71K | 82.47%-947.54K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.